Comments

Achieve Life Sciences (ACHV) Stock Price, Quote, News & History

ACHVNASDAQ
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$4.59
-0.15-3.16%
At close: -
$4.50
-0.09-1.93%
After Hours: Nov 7, 7:40 PM EDT
Q3 2025 Earnings were released on Thu Nov 6th, before the market open
The most recent conference call started at 8:30 AM, 3 days agoClick to view the webcast

Overview

NewsEarningsOptionsAnalyst RatingsInsider TradesShort InterestStock Report
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
$4.67
Close
$4.59
Volume / Avg.
928.13K / 1.50M
Day Range
$4.27 - $4.67
52 Wk Range
1.84 - 5.78
Market Cap
$230.04M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
10.89%
Days to Cover
7.36

Recent Achieve Life Sciences Inc News

4 Biotech Stocks Lifting Off As Momentum Builds

Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and major indexes reach record levels.
Dylan Berman

FDA Unveils First Experimental Drugs Under Fast-Track Voucher Plan To Cut Drug Review Times

The FDA launched a new voucher program to fast-track reviews, naming nine experimental drugs for cancer, diabetes, addiction, and other conditions.
Vandana Singh

Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Analyst Trends and Forecast

1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Key Statistics

Open
$4.67
Close
$4.59
Volume / Avg.
928.13K / 1.50M
Day Range
$4.27 - $4.67
52 Wk Range
1.84 - 5.78
Market Cap
$230.04M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
53
Short Interest
10.89%
Days to Cover
7.36

About

Sector
Health Care
Industry
Biotechnology
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been app...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ACHV
ZURA

FAQ

Q

How do I buy Achieve Life Sciences (ACHV) stock?

A

You can purchase shares of Achieve Life Sciences (NASDAQ:ACHV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Achieve Life Sciences (ACHV) competitors?

A

Other companies in Achieve Life Sciences’s space includes: Zura Bio (NASDAQ:ZURA), Cabaletta Bio (NASDAQ:CABA), Humacyte (NASDAQ:HUMA), ProQR Therapeutics (NASDAQ:PRQR) and Voyager Therapeutics (NASDAQ:VYGR).

Q

What is the forecast, or price target, for Achieve Life Sciences (ACHV) stock?

A

Achieve Life Sciences has a consensus price target of $13.43.

Q

What is the current price for Achieve Life Sciences (ACHV)?

A

The stock price for Achieve Life Sciences (NASDAQ: ACHV) is $4.5013 last updated November 7, 2025 at 7:40 PM EST.

Q

Does Achieve Life Sciences (ACHV) pay a dividend?

A

There are no upcoming dividends for Achieve Life Sciences.

Q

When is Achieve Life Sciences (NASDAQ:ACHV) reporting earnings?

A

Achieve Life Sciences’s Q3 earnings are confirmed for Thursday, November 6, 2025.

Q

Is Achieve Life Sciences (ACHV) going to split?

A

There is no upcoming split for Achieve Life Sciences.

Q

What sector and industry does Achieve Life Sciences (ACHV) operate in?

A

Achieve Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved